1033:HKEXSinopec Oilfield Service Corporation Analysis
Data as of 2026-09-09 - not real-time
HK$0.71
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At HKD 0.7100, Sinopec Oilfield Service Corporation shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 10.9%. With RSI at 69.9 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at HKD 0.6350 and resistance at HKD 0.7100.
On valuation the read is fair — earnings multiple of 17.8 versus a 18.1 sector average, in line with the peer group. Analyst price targets sit 17.8% above the current price.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 24.0%, a beta of 0.16 and a maximum drawdown of 63.2%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
On valuation the read is fair — earnings multiple of 17.8 versus a 18.1 sector average, in line with the peer group. Analyst price targets sit 17.8% above the current price.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 24.0%, a beta of 0.16 and a maximum drawdown of 63.2%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 0.78
- MACD momentum is positive
- 30-day price change of +10.9%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 17.8 versus sector average of 18.1
- Trading below the 200-day average of 0.78
- Analyst targets imply +17.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 17.8 versus sector average of 18.1
- Analyst targets imply +17.8% versus the current price
- Elevated debt-to-equity of 321
Key Metrics & Analysis
Financial Health
Revenue Growth1.00%
Profit Margin0.83%
P/E Ratio17.8
ROE7.01%
ROA1.64%
Debt/Equity320.64
P/B Ratio1.2
Op. Cash FlowHK$7.4B
Free Cash FlowHK$63.3M
Industry P/E18.1
Technical Analysis
TrendNeutral
RSI69.9
SupportHK$0.63
ResistanceHK$0.71
MA 20HK$0.66
MA 50HK$0.64
MA 200HK$0.78
MACDBullish
VolumeIncreasing
Fear & Greed Index92.32
Valuation
Target PriceHK$0.84
Upside/Downside17.80%
GradeFair
TypeBlend
Risk Assessment
Beta0.16
Volatility24.02%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.